Observational Prospectif Monocentric Registry of Patients Suffering From VIE (REMOTEV)

University Hospital, Strasbourg, France

Status: Completed

Conditions: Venous Thromboembolic Disease

Study type: Observational

Funder types: Other

Identifiers

NCT02188056

003-14

Details and patient eligibility

About

Patients with an episode of VTE (DVT and / or PE) have a mortality rate of 16-21% at 1 year after diagnosis. Morbidity associated with VTE is marked by the risk of recurrence, estimated at 30% and estimated at 29% after 8 years of follow post-thrombotic syndrome. For a number of these patients, risk factors have been identified (congenital or acquired thrombophilia, cancer, postpartum, surgery, prolonged immobilization, etc..). In 25-50% of cases, the etiology remains unknown, justifying the need for well-conducted studies to determine other potential risk factors. In addition, the expansion of treatment options with the arrival on the market of new direct oral anticoagulants, allows comparative studies on the effectiveness and frequency of adverse events for each treatment.

Enrollment: 300 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• diagnosis of venous thromboembolism established by a validated test (venous Doppler ultrasound of the lower limbs, pulmonary angiography, lung scan ventilation / perfusion),
• diagnosis of venous thromboembolism made within 15 days,
• the previous inclusion in the register (outpatient or inpatient)

Exclusion criteria

• person doesn't wish to participate in this study